Merck Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Merck's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Merck in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
88.1289.4490.76
Details
Intrinsic
Valuation
LowReal ValueHigh
88.9090.2291.54
Details
Naive
Forecast
LowNext ValueHigh
90.0191.3392.65
Details
17 Analysts
Consensus
LowTarget PriceHigh
70.0090.88110.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Merck. Your research has to be compared to or analyzed against Merck's peers to derive any actionable benefits. When done correctly, Merck's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Merck Company.

Merck Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Merck and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Merck and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Merck Company does not affect the price movement of the other competitor.
LZB
CAT
CVX
MSFT
INTC
LZB
-0.16-0.130.71-0.08
LZB
CAT
-0.160.960.150.73
CAT
CVX
-0.130.960.180.68
CVX
MSFT
0.710.150.180.07
MSFT
INTC
-0.080.730.680.07
INTC
LZB
CAT
CVX
MSFT
INTC
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Merck Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Merck stock performing well and Merck company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Merck's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Merck Company and related stocks such as La-Z-Boy, Caterpillar, Chevron Corp, Microsoft Corp, and Intel Corp Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
LZB106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M106.5 M150 M126.8 M
CAT4.9 B4.9 B5.7 B3.8 B2.5 B2.5 B(67 M)754 M6.1 B6.1 BB6.5 B5.6 B
CVX26.9 B26.9 B26.2 B21.4 B19.2 B4.6 B(497 M)9.2 B14.8 B2.9 B(5.5 B)15.6 B13.4 B
MSFT17 B17 B21.9 B22.1 B12.2 B20.5 B25.5 B16.6 B39.2 B44.3 B61.3 B72.7 B78.5 B
INTC19.9 B12.9 B19.9 B19.9 B19.9 B19.9 B10.3 B19.9 B19.9 B19.9 B19.9 B10.3 B13.8 B

Merck Company and related stocks such as La-Z-Boy, Caterpillar, Chevron Corp, Microsoft Corp, and Intel Corp Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Merck Company financial statement analysis. It represents the amount of money remaining after all of Merck Company operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Merck Competitive Analysis

The better you understand Merck competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Merck's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Merck's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MRKLZBCATCVXMSFTINTC
 1.16 
 89.52 
Merck
 4.04 
 27.77 
La Z
 0.12 
 186.03 
Caterpillar
 1.30 
 155.41 
Chevron
 0.71 
 282.30 
Microsoft
 2.43 
 34.52 
Intel
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Merck Competition Performance Charts

Complement your Merck position

In addition to having Merck in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ISP Thematic Idea Now

ISP
ISP Theme
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
View All  Next Launch
Additionally, see Merck Correlation with its peers. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.54
Market Capitalization
221.4 B
Quarterly Revenue Growth YOY
0.28
Return On Assets
0.13
Return On Equity
0.43
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MRK
 Stock
  

USD 89.52  1.03  1.16%   

Merck Company competes with La Z, Caterpillar, Chevron Corp, Microsoft Corp, and Intel Corp; as well as few others. The company runs under Healthcare sector within Drug Manufacturers—General industry. Analyzing Merck competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Merck to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Merck competition on your existing holdings. Additionally, see Merck Correlation with its peers.
  
The current Return on Investment is estimated to increase to 21.07, while Return on Average Assets are projected to decrease to 0.11. Merck Net Current Assets as percentage of Total Assets are decreasing as compared to previous years. The last year's value of Net Current Assets as percentage of Total Assets was reported at 6.05. The current Asset Turnover is estimated to increase to 0.53, while Assets Non Current are projected to decrease to under 67.7 B.